Skip to main content
Jones Nauseef, MD, Oncology, New York, NY, New York-Presbyterian Hospital

JonesTrevorNauseefMDPhD

Oncology New York, NY

Hematologic Oncology

Assistant Professor

Overview of Dr. Nauseef

Dr. Jones Nauseef is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Hospital. He received his medical degree from University of Iowa Roy J. and Lucille A. Carver College of Medicine and has been in practice 7 years. He is one of 368 doctors at New York-Presbyterian Hospital and one of 368 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 10 publications and over 450 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2015 - 2018
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2015

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2018 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Robust PSA Drops with Radionuclide Therapy in Castration-Resistant Prostate Cancer
    Robust PSA Drops with Radionuclide Therapy in Castration-Resistant Prostate CancerApril 18th, 2023
  • ASCO GU 2021: Prevalence of Microsatellite Instability and Monitoring Response to Immune Checkpoint Inhibition Utilizing Liquid Biopsy Among African American Men with Advanced Prostate Cancer
    ASCO GU 2021: Prevalence of Microsatellite Instability and Monitoring Response to Immune Checkpoint Inhibition Utilizing Liquid Biopsy Among African American Men with Advanced Prostate CancerFebruary 12th, 2021
  • ASCO GU 2021: Multi-Institutional Evaluation of the Clinical Outcomes and Genomic Correlates of African Americans with Metastatic Castration-Sensitive Prostate Cancer
    ASCO GU 2021: Multi-Institutional Evaluation of the Clinical Outcomes and Genomic Correlates of African Americans with Metastatic Castration-Sensitive Prostate CancerFebruary 11th, 2021
  • Join now to see all

Hospital Affiliations